GlassScriptPhysician profile
Thomas P Mead
NPI 1871554071
$5,466.00
in general payments reported to CMS, 2019-2025
39 companies · $737 in 2025
The $737 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $643 · 2021: $962 · 2022: $1,148 · 2023: $476 · 2024: $825 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.27 |
| Education | $173.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,163.80 | 2019-2023 | |
| Amgen INC. | $525.74 | 2020-2025 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $347.12 | 2022-2025 | |
| Hologic Sales and Service, LLC | $337.52 | 2019-2024 | Acessa Provu System, Aptima, Coolseal Generator |
| Organon LLC | $329.72 | 2021-2024 | Nexplanon |
| Myovant Sciences INC. | $329.44 | 2021-2022 | |
| Ethicon US, LLC | $287.22 | 2020-2025 | Vistaseal, Ethicon, Harmonic |
| Astellas Pharma US INC | $241.52 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $239.34 | 2019-2024 | Gardasil, Gardasil 9 |
| Novo Nordisk INC | $238.59 | 2019-2025 | Wegovy |
| Pfizer INC. | $183.85 | 2019-2024 | |
| Coopersurgical, INC. | $160.09 | 2019-2025 | Paragard T 380a, Ally II Ups, Paragard T 380a |
| Therapeuticsmd, INC. | $117.38 | 2019-2022 | |
| Millicent US INC | $100.10 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Galderma Laboratories, L.P. | $94.97 | 2019 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $83.74 | 2019-2020 | |
| Medical Device Business Services, INC. | $67.54 | 2024 | Harmonic |
| Lilly USA, LLC | $67.20 | 2023-2025 | Zepbound |
| Sumitomo Pharma America, INC. | $60.05 | 2023-2024 | Myfembree |
| Biogen, INC. | $44.30 | 2024 | Zurzuvae |
| Shield Therapeutics INC | $42.66 | 2022-2024 | |
| Vertical Pharmaceuticals, LLC | $35.01 | 2019 | |
| Scynexis, INC. | $33.83 | 2022 | |
| Agile Therapeutics, INC. | $33.50 | 2022 | |
| Ardelyx, INC. | $30.85 | 2024-2025 | Ibsrela |
| Duchesnay USA Incorporated | $26.48 | 2019 | |
| Davol INC. | $25.49 | 2023 | Arista Ah Flexitip |
| Becton, Dickinson and Company | $25.25 | 2025 | Arista |
| Minerva Surgical, INC | $24.32 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $22.88 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Coloplast Corp | $22.32 | 2022 | |
| Medicem INC. | $20.26 | 2021 | |
| Daiichi Sankyo INC. | $19.42 | 2024 | Injectafer |
| Integra Lifesciences Corporation | $17.06 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Mycovia Pharmaceuticals, INC. | $16.99 | 2023 | Vivjoa |
| Lupin INC. | $13.20 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.68 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.